You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson
Colorcon

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Litigation Details for Senju Pharmaceutical Co. Ltd. v. Lupin Limited (D. Del. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Senju Pharmaceutical Co. Ltd. v. Lupin Limited
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for Senju Pharmaceutical Co. Ltd. v. Lupin Limited (D. Del. 2011)

Date Filed Document No. Description Snippet Link To Document
2012-11-13 129 on the Pleadings that the Claims of U.S. Patent No. 6,333,045 Are Invalid and Not Infringed filed by Lupin…2011 9 August 2013 1:11-cv-00271 830 Patent Defendant District Court, D. External link to document
2012-11-14 131 on the Pleadings that the Claims of U.S. Patent No. 6,333,045 Are Invalid and Not Infringed. (Noreika,…2011 9 August 2013 1:11-cv-00271 830 Patent Defendant District Court, D. External link to document
2012-11-28 134 on the Pleadings that the Claims of U.S. Patent No. 6,333,045 are Invalid and Not Infringed by Allergan…2011 9 August 2013 1:11-cv-00271 830 Patent Defendant District Court, D. External link to document
2012-12-07 135 alleging infringement of U.S. Patent Nos. 6,333,045 ("the '045 patent") and 5,880,283 ("…on the Pleadings that the Claims of U.S. Patent No. 6,333,045 Are Invalid and Not Infringed. Signed by…#39;045 patent as reexamined. (D.I. 33) The next alleged infringement of the '045 patent as reexamined…invalidity in one patent action operates to bar relitigation of the validity of the same patent in a subsequent…part, as follows: 1. Background. This patent infringement litigation was initiated on March External link to document
2012-12-14 137 alleging infringement of U.S. Patent Nos. 6,333,045 ("the '045 patent") and 5,880,283 ("…granted, as follows: 1. Background. This patent infringement litigation was initiated on March …quot;the '283 patent") by defendants' Abbreviated New Drug Application ("ANDA"…quot;) No. 202-653. 1 (D.I. 1) The '045 patent is directed to aqueous liquid pharmaceutical compositions…reexamination of claims 1-3, 6, 8 and 9 of the '045 patent. (D. I. 10 at~~ 47-48) Defendants filed External link to document
2013-04-12 173 United States 24 patent 6,333,045 that we'll call the '045 patent. And this …off, the '470 prior art patent. This is 22 the patent that discloses gatifloxacin…prior 10 art '456 patent. This is one of the patents that discloses 11 literally…Honor, in the Patent Office, 22 and then told them somehow that this was patentable. …what this 11 patent at JTX-1 relates to? 12 A. This patent is about the improvement External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Mallinckrodt
Dow
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.